Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment.
Anticancer Res. 2021 Apr;41(4):2203-2207. doi: 10.21873/anticanres.14996.
Anticancer Res. 2021.
PMID: 33813435